PLLA patent discloses stronger stent approach

09/07/2012

Elixir Medical Corp. (Sunnyvale, CA) is the first company to offer both durable and biodegradable platforms for drug-eluting stents. A proprietary annealling approach boosts crystallinty and strength for its plastic stent.

The company announced that it now has CE (Conformité Européenne) Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease. The Novolimus Eluting DESyne stent is based on a cobalt chromium platform....Read more www.k-online.de

Further on-line features of Messe Düsseldorf GmbH in this field of competence Machinery, Plant and Equipment: